GSK-205180

Study Sponsor: GSK

Study Title

A Phase IIa, Double-Blind, Mechanistic Study of GSK3196165 in Combination with Methotrexate Therapy in Subjects with Active Rheumatoid Arthritis Despite Treatment with DMARDs

Medicine or Vaccine (generic name)

otilimab

Sponsor Identification Number

205180

Trial Registry Identification Number(#'s)

NCT02799472

Medical Condition

Arthritis, Rheumatoid

Phase

Phase 2

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=205180

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT02799472

Link to study details on EudraCT (if available)

https://www.clinicaltrialsregister.eu/ctr-search/search?query=/2015-004386-91

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

An annotated case report form is not available for this study. A blank case report form will be provided. This study is available in CDISC format.

Date Added to this Site

November 2020